SHD Human Pre-designed siRNA Set A contains three designed siRNAs for SHD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHE Human Pre-designed siRNA Set A contains three designed siRNAs for SHE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHF Human Pre-designed siRNA Set A contains three designed siRNAs for SHF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHFL Human Pre-designed siRNA Set A contains three designed siRNAs for SHFL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHH Human Pre-designed siRNA Set A contains three designed siRNAs for SHH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Shikimate-3-phosphate lithium is the salt form of Shikimate-3-phosphate. Shikimate-3-phosphate lithium is a central microbial, parasite and plant metabolite, as a product of the shikimate kinase-catalysed reaction. Shikimate-3-phosphate lithium serves as an enzyme substrate for 5-enolpyruvoyl-shikimate 3-phosphate synthase, which is a target of anti-infectives and of herbicides[1].

SHISA2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHISA3 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHISA5 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHISA6 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHISA7 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHISA9 Human Pre-designed siRNA Set A contains three designed siRNAs for SHISA9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for SHLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHLD2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHLD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHLD3 Human Pre-designed siRNA Set A contains three designed siRNAs for SHLD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for SHMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHOC2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHOC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHOX Human Pre-designed siRNA Set A contains three designed siRNAs for SHOX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHOX2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHOX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHP2-IN-25 (Compound 6) is a SHP2 allosteric inhibitor, with an IC50 of 225 nM. SHP2-IN-25 can be used for the research of cancer[1].

SHP2-IN-26 (Compound 4b) is a highly selective SHP2 allosteric inhibitor with a IC50 value of 3.2 nM. SHP2-IN-26 inhibits the phosphorylation of ERK and AKT in NCI-H358 cells. SHP2-IN-26 has antitumor activity[1].

SHP2-IN-27 (compound 28) is an allosteric inhibitor of tyrosine phosphatase SH2[1].

SHP2-IN-28 (Compound 7188-0011) is an inhibitor of SHP2 (IC50=54.31 μM). SHP2-IN-28 exerts its inhibitory effect by binding to the variable site of SHP2 with high selectivity[1].

SHPK Human Pre-designed siRNA Set A contains three designed siRNAs for SHPK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHPRH Human Pre-designed siRNA Set A contains three designed siRNAs for SHPRH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHQ1 Human Pre-designed siRNA Set A contains three designed siRNAs for SHQ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHROOM1 Human Pre-designed siRNA Set A contains three designed siRNAs for SHROOM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHROOM2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHROOM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHROOM3 Human Pre-designed siRNA Set A contains three designed siRNAs for SHROOM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHROOM4 Human Pre-designed siRNA Set A contains three designed siRNAs for SHROOM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SHTN1 Human Pre-designed siRNA Set A contains three designed siRNAs for SHTN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SI Human Pre-designed siRNA Set A contains three designed siRNAs for SI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIAE Human Pre-designed siRNA Set A contains three designed siRNAs for SIAE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIAH1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIAH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIAH2 Human Pre-designed siRNA Set A contains three designed siRNAs for SIAH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIAH3 Human Pre-designed siRNA Set A contains three designed siRNAs for SIAH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sibiriquinone A is a diterpene with immunosuppressive activity that can be isolated from the aerial parts of Veronicastrum sibiricum. Sibiriquinone A[1].

SIDT1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIDT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIDT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SIDT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIGIRR Human Pre-designed siRNA Set A contains three designed siRNAs for SIGIRR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIGLEC1 Human Pre-designed siRNA Set A contains three designed siRNAs for SIGLEC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIGLEC10 Human Pre-designed siRNA Set A contains three designed siRNAs for SIGLEC10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIGLEC11 Human Pre-designed siRNA Set A contains three designed siRNAs for SIGLEC11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SIGLEC12 Human Pre-designed siRNA Set A contains three designed siRNAs for SIGLEC12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.